For global studies, research material and active pharmaceutical ingredients (APIs) are often shipped to sites in different countries from a central manufacturing base. This means that taxes or VAT must be paid on the product upon entering each country, and as each country has different procedures, this can be confusing for companies that have little…
What is the best next use of artificial intelligence (AI)? Many people would say drug development. And arguably they would be right. However, that’s not something for the future, when AI becomes more refined. Recursion Pharmaceuticals (NASDAQ:RXRX) He’s doing it right now. Its platform called Recursion OS leverages 65 petabytes (65 million gigabytes) of chemical…
Against a backdrop of rapid innovation, the pharmaceutical services industry is undergoing a wave of consolidation that is fundamentally reshaping competitive dynamics and creating threats and opportunities for clinical technology providers and contract research organizations (CROs). A recent example is Thermo Fisher Scientific’s acquisition of Clario Holdings, an electronic endpoint data and clinical outcome assessment…
Swiss drugmaker Novartis said on Sunday it has agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash, as the company looks to bolster its portfolio of treatments for rare muscle disorders. Under the terms of the deal, Avidity shareholders will receive $72 per share in cash, representing a 46% premium…
